Incidence of venous thromboembolic events in cancer patients receiving immunotherapy: a single-institution experience.

MLA

Gutierrez-Sainz, L., et al. “Incidence of Venous Thromboembolic Events in Cancer Patients Receiving Immunotherapy: A Single-Institution Experience.” Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 23, no. 6, June 2021, pp. 1245–52. EBSCOhost, https://doi.org/10.1007/s12094-020-02515-3.

APA

Gutierrez-Sainz, L., Martinez-Marin, V., Viñal, D., Martinez-Perez, D., Pedregosa, J., Garcia-Cuesta, J. A., Villamayor, J., Zamora, P., Pinto, A., Redondo, A., Castelo, B., Cruz, P., Higuera, O., Custodio, A., Gallego, A., Sanchez-Cabrero, D., de Castro-Carpeño, J., Espinosa, E., & Feliu, J. (2021). Incidence of venous thromboembolic events in cancer patients receiving immunotherapy: a single-institution experience. Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 23(6), 1245–1252. https://doi.org/10.1007/s12094-020-02515-3

Chicago

Gutierrez-Sainz, L, V Martinez-Marin, D Viñal, D Martinez-Perez, J Pedregosa, J A Garcia-Cuesta, J Villamayor, et al. 2021. “Incidence of Venous Thromboembolic Events in Cancer Patients Receiving Immunotherapy: A Single-Institution Experience.” Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 23 (6): 1245–52. doi:10.1007/s12094-020-02515-3.